Wall Street analysts are maintaining Buy rating on Cognex Corporation (NASDAQ:CGNX) company shares. The one year target on the name currently stands at $41.63. The stock recently touched $39.59 and has moved in the range of $39.00 - 39.97 during the current session. Based on a recent bid this places the stock +41.34% away from the 52-week floor of $28.01 and -24.56% away from the 52-week ceiling of $52.48.
When stocks are given “Buy” ratings by analysts, the reasons or criteria for that recommendation can greatly vary. Typically when a stock is given this label, analysts are expecting that the stock will outperform their peers, their sector or the market over a 6 to 12 month time frame. Several factors might include near-term catalysts, future earnings growth. Many analysts only give a Buy recommendation when they expect that the stock will yield a return of at least 5-10% over the course of a year. Since analyst criteria and recommendation terminology can differ, we can look at consensus numbers to get a feel of overall analyst sentiment.
MKS Instruments, Inc. (NASDAQ:MKSI) has been given a consensus Buy rating by analysts on Wall Street. According to Thomson Reuters' First Call, research brokers have a one year price target of $40.40 on the stock. The stock is currently trading -2.16% away from its 200-day moving average of $34.51. Based on a recent trade, shares of MKS Instruments, Inc. are -14.85% away from the 52-week high of $39.65 and +16.41% away from the 52-week low of $29.00.
Analysts are estimating that the company will report earnings of $2.16 for the current year and $0.51 for next quarter. The stock closed the most recent trading session at $33.43.
Shares of Chiasma Inc (NASDAQ:CHMA) continue to be viewed favorably by equities brokerage firms on Wall Street. The First Call consensus which is calculated by Thomson Reuters has a $41.50 price target and Buy rating according to the covering analysts. During today’s session the stock hit $10.12 or -0.98% from the previous close, while moving in the range of $10.08 - 10.28.
Shares of Myokardia Inc (NASDAQ:MYOK) continue to be viewed favorably by equities brokerage firms on Wall Street. The First Call consensus which is calculated by Thomson Reuters has a $19.330 price target according to the covering analysts. During today’s session the stock hit $7.560 or -0.595% from the previous close, while moving in the range of $7.500 - 7.710. This puts the stock -55.161% away from the 52-week high of $16.760 and +20.433% away from the 52-week low of $6.240.
Exact definitions of a “Buy” rating can greatly vary depending on the equity research firm. The consensus rating simply provides an average of those recommendations. It's important to note that a “Buy” rating does not mean that every investor should acquire the stock. It is just a single factor among many that should be considered before making an investment decision.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
